May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Avastine Injections Into Sub-tenon’s Space Prior to Surgical Treatment for Diabetic Proliferative Retinopathy
Author Affiliations & Notes
  • T. M. Dzhusoev
    Saint-Petersburg affiliate, S N Fyodorov's Eye Microsurgery Complex, Saint-Petersburg, Russian Federation
  • Y. V. Bayborodov, Jr.
    Saint-Petersburg affiliate, S N Fyodorov's Eye Microsurgery Complex, Saint-Petersburg, Russian Federation
  • Footnotes
    Commercial Relationships  T.M. Dzhusoev, None; Y.V. Bayborodov, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2729. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. M. Dzhusoev, Y. V. Bayborodov, Jr.; Avastine Injections Into Sub-tenon’s Space Prior to Surgical Treatment for Diabetic Proliferative Retinopathy. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2729. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To study effects of sub-Tenon’s injections of Avastive on course of neoangiogenesis and ability of Avastine to cause detachment of posterior hyaloid in complex surgical treatment of patients with diabetic proliferative retinopathy.

Methods: : Twenty-eight eyes of fourteen patients diagnosed with type I diabetes mellitus and diabetic proliferative retinopathy in both eyes, underwent eye surgical treatment. Seven days prior to the surgery all patients received injection of Avastine, 5 mg, into sub-Tenon’s space. Surgical treatment included vitrectomy with posterior hyaloid membrane (PHM) removal. Pre- and post-operative methods of evaluation included fundoscopy, B-scanning, optical coherent tomography (OCT) and photography.

Results: : Significant regress of new vessels on PHM was observed within pre-operative week following Avastine injection in all patients. One week after the injection, fundoscopy, B-scan, OCT and photography revealed enlargement of macular edema area in patients with attached macula and increased retinal detachment height along with partial PHM detachment in patients with detached macula.Intra-operative bleeding during PHM peeling was avoided in 13 out of 14 patients.

Conclusions: : Sub-Tenon’s injection of 5 mg Avastine one week prior to surgical treatment in patients with diabetic proliferative retinopathy results in significant regress of vitreoretinal neovascularization and induces PHM detachment.

Keywords: diabetic retinopathy • inhibitory receptors • vitreoretinal surgery 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×